Filing Details
- Accession Number:
- 0001209191-13-055888
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-09 15:32:16
- Reporting Period:
- 2013-12-06
- Filing Date:
- 2013-12-09
- Accepted Time:
- 2013-12-09 15:32:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1491874 | M. Geoffrey Parker | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-12-06 | 5,000 | $5.15 | 9,600 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2013-12-06 | 15,000 | $5.15 | 15,000 | No | 4 | P | Indirect | By Geoffrey M Parker and Jill Gofen Parker Trustees of Geoffrey M Parker and Jill G Parker Revocable |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | By Geoffrey M Parker and Jill Gofen Parker Trustees of Geoffrey M Parker and Jill G Parker Revocable |
Footnotes
- Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $5.12 to $5.16 per share, inclusive. The Reporting Person will provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
- Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $5.11 to $5.16 per share, inclusive. The Reporting Person will provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
